29/04/2003 - 22:00

Contracts

29/04/2003 - 22:00

Bookmark

Save articles for future reference.

Solbec Pharmaceuticals Ltd 28/4/03 Has secured funding from the Federal Government's Biotechnology Innovation Fund to develop research on its anti-cancer drug SBP002. The BiotechnologyInnovation Fund will fund half the $393,768 project. Trial results are expected in September 2004.  

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options